Home Cart Sign in  
Chemical Structure| 30727-14-1 Chemical Structure| 30727-14-1

Structure of 30727-14-1

Chemical Structure| 30727-14-1

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of [ 30727-14-1 ]

CAS No. :30727-14-1
Formula : C6H13NO
M.W : 115.17
SMILES Code : OC1CN(CC)CC1
MDL No. :MFCD00003179
InChI Key :IDBNECMSCRAUNU-UHFFFAOYSA-N
Pubchem ID :98203

Safety of [ 30727-14-1 ]

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H227-H315-H319
Precautionary Statements:P210-P305+P351+P338

Computational Chemistry of [ 30727-14-1 ] Show Less

Physicochemical Properties

Num. heavy atoms 8
Num. arom. heavy atoms 0
Fraction Csp3 1.0
Num. rotatable bonds 1
Num. H-bond acceptors 2.0
Num. H-bond donors 1.0
Molar Refractivity 36.81
TPSA ?

Topological Polar Surface Area: Calculated from
Ertl P. et al. 2000 J. Med. Chem.

23.47 Ų

Lipophilicity

Log Po/w (iLOGP)?

iLOGP: in-house physics-based method implemented from
Daina A et al. 2014 J. Chem. Inf. Model.

1.64
Log Po/w (XLOGP3)?

XLOGP3: Atomistic and knowledge-based method calculated by
XLOGP program, version 3.2.2, courtesy of CCBG, Shanghai Institute of Organic Chemistry

0.14
Log Po/w (WLOGP)?

WLOGP: Atomistic method implemented from
Wildman SA and Crippen GM. 1999 J. Chem. Inf. Model.

-0.31
Log Po/w (MLOGP)?

MLOGP: Topological method implemented from
Moriguchi I. et al. 1992 Chem. Pharm. Bull.
Moriguchi I. et al. 1994 Chem. Pharm. Bull.
Lipinski PA. et al. 2001 Adv. Drug. Deliv. Rev.

0.21
Log Po/w (SILICOS-IT)?

SILICOS-IT: Hybrid fragmental/topological method calculated by
FILTER-IT program, version 1.0.2, courtesy of SILICOS-IT, http://www.silicos-it.com

0.51
Consensus Log Po/w?

Consensus Log Po/w: Average of all five predictions

0.44

Water Solubility

Log S (ESOL):?

ESOL: Topological method implemented from
Delaney JS. 2004 J. Chem. Inf. Model.

-0.58
Solubility 30.6 mg/ml ; 0.265 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Very soluble
Log S (Ali)?

Ali: Topological method implemented from
Ali J. et al. 2012 J. Chem. Inf. Model.

-0.19
Solubility 74.5 mg/ml ; 0.647 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Very soluble
Log S (SILICOS-IT)?

SILICOS-IT: Fragmental method calculated by
FILTER-IT program, version 1.0.2, courtesy of SILICOS-IT, http://www.silicos-it.com

-0.26
Solubility 63.9 mg/ml ; 0.555 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Soluble

Pharmacokinetics

GI absorption?

Gatrointestinal absorption: according to the white of the BOILED-Egg

Low
BBB permeant?

BBB permeation: according to the yolk of the BOILED-Egg

No
P-gp substrate?

P-glycoprotein substrate: SVM model built on 1033 molecules (training set)
and tested on 415 molecules (test set)
10-fold CV: ACC=0.72 / AUC=0.77
External: ACC=0.88 / AUC=0.94

No
CYP1A2 inhibitor?

Cytochrome P450 1A2 inhibitor: SVM model built on 9145 molecules (training set)
and tested on 3000 molecules (test set)
10-fold CV: ACC=0.83 / AUC=0.90
External: ACC=0.84 / AUC=0.91

No
CYP2C19 inhibitor?

Cytochrome P450 2C19 inhibitor: SVM model built on 9272 molecules (training set)
and tested on 3000 molecules (test set)
10-fold CV: ACC=0.80 / AUC=0.86
External: ACC=0.80 / AUC=0.87

No
CYP2C9 inhibitor?

Cytochrome P450 2C9 inhibitor: SVM model built on 5940 molecules (training set)
and tested on 2075 molecules (test set)
10-fold CV: ACC=0.78 / AUC=0.85
External: ACC=0.71 / AUC=0.81

No
CYP2D6 inhibitor?

Cytochrome P450 2D6 inhibitor: SVM model built on 3664 molecules (training set)
and tested on 1068 molecules (test set)
10-fold CV: ACC=0.79 / AUC=0.85
External: ACC=0.81 / AUC=0.87

No
CYP3A4 inhibitor?

Cytochrome P450 3A4 inhibitor: SVM model built on 7518 molecules (training set)
and tested on 2579 molecules (test set)
10-fold CV: ACC=0.77 / AUC=0.85
External: ACC=0.78 / AUC=0.86

No
Log Kp (skin permeation)?

Skin permeation: QSPR model implemented from
Potts RO and Guy RH. 1992 Pharm. Res.

-6.9 cm/s

Druglikeness

Lipinski?

Lipinski (Pfizer) filter: implemented from
Lipinski CA. et al. 2001 Adv. Drug Deliv. Rev.
MW ≤ 500
MLOGP ≤ 4.15
N or O ≤ 10
NH or OH ≤ 5

0.0
Ghose?

Ghose filter: implemented from
Ghose AK. et al. 1999 J. Comb. Chem.
160 ≤ MW ≤ 480
-0.4 ≤ WLOGP ≤ 5.6
40 ≤ MR ≤ 130
20 ≤ atoms ≤ 70

None
Veber?

Veber (GSK) filter: implemented from
Veber DF. et al. 2002 J. Med. Chem.
Rotatable bonds ≤ 10
TPSA ≤ 140

0.0
Egan?

Egan (Pharmacia) filter: implemented from
Egan WJ. et al. 2000 J. Med. Chem.
WLOGP ≤ 5.88
TPSA ≤ 131.6

0.0
Muegge?

Muegge (Bayer) filter: implemented from
Muegge I. et al. 2001 J. Med. Chem.
200 ≤ MW ≤ 600
-2 ≤ XLOGP ≤ 5
TPSA ≤ 150
Num. rings ≤ 7
Num. carbon > 4
Num. heteroatoms > 1
Num. rotatable bonds ≤ 15
H-bond acc. ≤ 10
H-bond don. ≤ 5

1.0
Bioavailability Score?

Abbott Bioavailability Score: Probability of F > 10% in rat
implemented from
Martin YC. 2005 J. Med. Chem.

0.55

Medicinal Chemistry

PAINS?

Pan Assay Interference Structures: implemented from
Baell JB. & Holloway GA. 2010 J. Med. Chem.

0.0 alert
Brenk?

Structural Alert: implemented from
Brenk R. et al. 2008 ChemMedChem

0.0 alert: heavy_metal
Leadlikeness?

Leadlikeness: implemented from
Teague SJ. 1999 Angew. Chem. Int. Ed.
250 ≤ MW ≤ 350
XLOGP ≤ 3.5
Num. rotatable bonds ≤ 7

No; 1 violation:MW<1.0
Synthetic accessibility?

Synthetic accessibility score: from 1 (very easy) to 10 (very difficult)
based on 1024 fragmental contributions (FP2) modulated by size and complexity penaties,
trained on 12'782'590 molecules and tested on 40 external molecules (r2 = 0.94)

1.53

Application In Synthesis of [ 30727-14-1 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Downstream synthetic route of [ 30727-14-1 ]

[ 30727-14-1 ] Synthesis Path-Downstream   1~23

  • 1
  • [ 19398-47-1 ]
  • [ 75-04-7 ]
  • [ 30727-14-1 ]
  • 2
  • [ 30727-14-1 ]
  • [ 2942-59-8 ]
  • Sodium; 2-(1-ethyl-pyrrolidin-3-yloxy)-nicotinate [ No CAS ]
  • 3
  • [ 30727-14-1 ]
  • 3-[4-(2-piperidin-1-yl-ethoxy)-benzyl]-2-(4-triisopropylsilanyloxy-phenyl)-benzo[<i>b</i>]thiophen-6-ol [ No CAS ]
  • 2-[4-(1-ethyl-pyrrolidin-3-yloxy)-phenyl]-3-[4-(2-piperidin-1-yl-ethoxy)-benzyl]-benzo[<i>b</i>]thiophen-6-ol [ No CAS ]
  • 5
  • 1-ethyl-pyrrolidin-3-one [ No CAS ]
  • [ 30727-14-1 ]
  • 6
  • [ 75-04-7 ]
  • (+-)-1,4-dichloro-butan-2-ol [ No CAS ]
  • [ 30727-14-1 ]
  • 7
  • [ 30727-14-1 ]
  • [ 109-00-2 ]
  • 3-(1-Ethyl-3-pyrrolidinyloxy)-pyridine [ No CAS ]
  • 8
  • [ 30727-14-1 ]
  • [ 98-59-9 ]
  • [ 957621-58-8 ]
  • 9
  • [ 30727-14-1 ]
  • [ 91836-98-5 ]
  • 10
  • [ 30727-14-1 ]
  • [ 91833-28-2 ]
  • 11
  • [ 30727-14-1 ]
  • [ 91837-18-2 ]
  • 12
  • [ 30727-14-1 ]
  • [ 313657-51-1 ]
  • [ 1106056-84-1 ]
YieldReaction ConditionsOperation in experiment
The title compound was prepared by using Mitsunobu condition from 4-(2-hydroxy-phenyl)-piperazine-1-carboxylic acid tert-butyl ester and 1-Ethyl-3-pyrrolidinol.
  • 13
  • [ 30727-14-1 ]
  • [ 616866-20-7 ]
YieldReaction ConditionsOperation in experiment
With sodium hydride; In N,N-dimethyl-formamide; 1 g (0.0042 mol) of 2-Cyclohexyl-2-fur-2-yl-2-hydroxyacetic acid methyl ester was dissolved in 12 ml of EtOH and 6 ml of a solution of NaOH 2N were added. This mixture was stirred at 60 for 1 hour. After this time, the EtOH was evaporated and the residue was acidified with HCI 10%. The aqueous solution was extracted with AcOEt (2 x 100 ml). the organic layers were combined, dried and evaporated to obtain a residue (2- cyclohexyl-2-fur-2-yl-2-hydroxyacetic acid) which was used without further purification. The acid obtained was dissolved in dry DMF (12 ml) and 0.817 g (0.005 mol) of 1,1'- carbonildimidazol were added. The mixture was stirred for 1 h at room temperature. After this time the sodium salt of 1-ethylpyrrolidin-3-ol (prepared by addition of HNa (0. 11g, 0.0046 mol) to a solution of 1-ethylpyrrolidin-3-ol (0. 531g, 0.0046 mol) in 5 ml of dry DMF) was added. After stirring 15 h at room temperature the reaction mixture was treated with water, and the aqueous phase was extracted with Et2O (2 x 100 ml). The organic phases were combined, washed with water and dried. After removal of the solvent the product obtained was purified by chromatography on silica gel eluting with chloroform plus isopropanol (5% 15%). The yield was 460 mg (34% related to starting methyl ester) of the title product. 'H-NMR (CDCI3) : 6 1.05-1. 45 (m, 10H), 1.60-2. 10 (m, 4H), 2.10-2. 35 (m, 2H), 2.40-2. 75 (m, 5H), 2.85-3. 0 (m, 1 H), 3.76 (bs, OH, 1 H), 5.27 (m, 1 H), 6.30-6. 40 (m, 2H), 7.39 (s, 1 H). MS [M+1]' : 322
  • 14
  • [ 30727-14-1 ]
  • [ 193966-49-3 ]
  • 4-[(1-Ethylpyrrolidin-3-yl)oxy]phenyl 2-[4-[2-(1-Pyrrolidinyl)ethoxy]phenyl]benzo[b]thiophen-3-yl Ketone [ No CAS ]
YieldReaction ConditionsOperation in experiment
63% In N,N-dimethyl-formamide; EXAMPLE 170 Preparation of 4-[(1-Ethylpyrrolidin-3-yl)oxy]phenyl 2-[4-[2-(1-Pyrrolidinyl)ethoxy]phenyl]benzo[b]thiophen-3-yl Ketone. STR515 Sodium hydride (60% oil dispersion, 38 mg) was suspended in DMF (1 mL) and stirred at ambient temperature for 15 min under argon before <strong>[30727-14-1]1-ethyl-3-pyrrolidinol</strong> (92 muL) was added. After stirring for 15 min, 4-fluorophenyl 2-[4-[2-(1-pyrrolidinyl)ethoxy]phenyl]benzo[b]thiophen-3-yl ketone (223 mg) in 1 mL of DMF was introduced and the resulting solution was stirred at ambient temperature for 4 h. The reaction mixture was diluted with brine (50 mL) and extracted with EtOAc (3*50 mL). The combined organic layers were dried (Na2 SO4) and concentrated under reduced pressure. Chromatography with Et3 N:MeOH:EtOAc (5:5:90) afforded the product as a colorless oil (171 mg, 63%). 1 H NMR (CDCl3): delta 7.85 (m, 1H), 7.75 (d, 2H), 7.65 (m, 1H), 7.35 (d, 2H), 7.32 (m, 2H), 6.78 (d, 2H), 6.71 (d, 2H), 4.80 (m, 1H), 4.03 (t, 2H), 2.85 (t, 2H), 2.80 (m, 2H), 2.60 (m, 4H), 2.50 (m, 4H), 2.28 (m, 1H), 1.92 (m, 1H), 1.08 (t, 3H).
  • 15
  • [ 94-71-3 ]
  • 1-ethyl-3,4-epoxypyrrolidine [ No CAS ]
  • [ 30727-14-1 ]
YieldReaction ConditionsOperation in experiment
With hydrogenchloride; sodium hydroxide; In dichloromethane; EXAMPLE 51 Trans-4-(2-ethoxypnenoxy)-1-ethyl-3-pyrrolidinol A mixture of 17.0 g. (0.15 mole) of 1-ethyl-3,4-epoxypyrrolidine, 22.1 g. (0.16 mole) of o-ethoxyphenol and 3 drops of concentrted hydrochloric acid was heated on a steam bath overnight. The oil was dissolved in methylene chloride and washed with three 50-ml. portions of 5% sodium hydroxide and one 50-ml. portion of water. The methylene chloride solution was dried over anhydrous sodium sulfate, concentrated and chromatographed on silica gel to give 8.1 g. (21%) of an oil which crystallized on standing. The solid was recrystallized from cyclohexane to yield a tan solid, m.p. 73-75 C. Analysis: Calculated for C14 H21 NO3: C,66.90; H,8.42; N,5.57; Found: C,66.49; H,8.43; N,5.48.
  • 16
  • [ 30727-14-1 ]
  • [ 182944-97-4 ]
  • [ 1005195-40-3 ]
  • 17
  • [ 30727-14-1 ]
  • [ 1061750-36-4 ]
  • [ 1061749-49-2 ]
  • 18
  • [ 30727-14-1 ]
  • [ 902767-82-2 ]
  • [ 902767-83-3 ]
YieldReaction ConditionsOperation in experiment
Under a dry nitrogen atmosphere, a stirred mixture of 0.24 mL (0.002 mole) of l-ethyl-3-pyrrolidinol in 5 mL of ethylene glycol dimethyl ether was cooled to0C and 1.38 mL of methyllithium (1.6 molar solution in diethyl ether, 0.0022 mole) was added. Upon completion of addition, the resultant mixture was stirred for ten minutes.A second reaction vessel was flushed with dry nitrogen and 0.2 gram of copper(I) chloride (0.002 mole) was added to it. The reaction mixture prepared EPO <DP n="31"/>above was then added to the copper(I) chloride and the mixture was stirred at ambient temperature for about 30 minutes. While maintaining a dry nitrogen atmosphere, 0.94 gram (0.0022 mole) of 5-((4-iodophenyl)methoxy)-l,2- dichloronaphthalene and 20 mL of pyridine were then added. Upon completion of addition, the reaction mixture was heated to reflux where it stirred for 48 hours. The mixture was then cooled and concentrated under reduced pressure to a residue. The residue was slurried in a mixture of ethyl acetate and water and the mixture was filtered through a pad of silicon dioxide filter agent. An organic phase was separated and was washed first with an aqueous copper(II) sulfate solution, then with a saturated aqueous sodium chloride solution. The organic phase was dried with anhydrous magnesium sulfate, filtered and the filtrate concentrated under reduced pressure to a residue. The residue was purified by column chromatography on silica gel, eluted with mixtures of 6% to 10% methanol in methylene chloride. The appropriate fractions were combined and concentrated under reduced pressure, yielding 0.13 gram of the title compound. The NMR spectrum was consistent with the proposed structure.
  • 19
  • [ 30727-14-1 ]
  • [ 64471-45-0 ]
  • (2R)-2-cyclopentyl-2-hydroxy-2-phenylacetic acid 1-ethylpyrrolidin-3-yl ester [ No CAS ]
YieldReaction ConditionsOperation in experiment
65% 0.655 g (0.00297 mol) of (2R)-2-Cyclopentyl-2-hydroxy-2-phenylacetic acid were dissolved in 8 ml of dry DMF. To this solution 0.580 g (0.0036 mol) of 1, 1'- carbonildiimidazol were added and the mixture was stirred at room temperature for 1 h. After this time, the mixture obtained was added to a suspension (cooled at 0C) of 1- ethylpyrrolidin-3-ol (0.390 ml g, 0.0033 mol) and HNa (0.078 g, 0.0033 mol) in 4 ml of dry DMF. After stirring 15 h at room temperature the reaction mixture was treated with water and extracted three times with Et2O. The organic layers were combined, washed with water and dried. The residue was purified by silica gel column chromatography (eluent : CHCI3 plus isopropanol 0%No.5%) to obtain 610 mg (65%) of the title product as an oil. 'H-NMR (CDCI3) :. 61. 05-1.15 (m, 3H), 1.25-1. 95 (m, 10H), 2.10-2. 35 (m, 1H), 2.40- 3.0 (m, 6H), 3.79 (bs, 1 H, OH), 5.23 (m, 1 H), 7.24-7. 36 (m, 3H), 7.65-7. 67 (m, 2H). MS [M+ir : 318
  • 20
  • [ 30727-14-1 ]
  • [ 847559-68-6 ]
  • [ 908002-40-4 ]
  • 21
  • [ 30727-14-1 ]
  • [ 2581-34-2 ]
  • [ 1246532-41-1 ]
YieldReaction ConditionsOperation in experiment
With di-isopropyl azodicarboxylate; triphenylphosphine; In tetrahydrofuran; at 20℃;Inert atmosphere; [00490] l-Ethyl-3-(3-methyl-4-nitro-phenoxy)-pyrrolidine (35a): To a magnetically stirred solution of 3-methyl-4-nitrophenol 34a (0.8 g, 5.09 mmol) in anhydrous THF (17 mL) was added DIAD (1.51 mL, 7.64 mmol), PPh3 (2 g, 7.64 mmol) and l-ethylpyrrolidin-3-ol (645 mg, 5.6 mmol) at room temperature and was allowed to stir overnight under nitrogen atmosphere. Upon completion, the solvent was evaporated under vacuum and the residue purified by silica gel flash chromatography (0- 100% MeOH/DCM) to yield l-ethyl-3-(3-methyl-4-nitrophenoxy) pyrrolidine 35a for which the structure was established based on proton NMR and mass spectroscopy.
  • 22
  • [ 30727-14-1 ]
  • C36H48N2O2 [ No CAS ]
  • C42H59N3O2 [ No CAS ]
YieldReaction ConditionsOperation in experiment
48% A 25 mL round bottom flask was charged with compound 39 Oxalyl chloride (240 mL, 2.5 mmol) and methylene chloride (10 mL) were then added to the flask, was stirred at room temperature for 24 hours and triethylamine (625 mul, 4.5 mmol) and 4-morpholinopropylamine (151 mg, 1.05 mmol) was added to the flask, and the mixture was stirred at room temperature for 8 hours.The residue was diluted with dichloromethane (100 mL), washed successively with 1M hydrochloric acid and saturated brine, dried over anhydrous sodium sulfate, filtered, concentrated and purified by column chromatography (dichloromethane / methanol = 50/1) to give Compound 48 (628 mg, 94 %). Compound 39 was reacted with <strong>[30727-14-1]1-ethyl-3-hydroxy-tetrahydropyrrole</strong> (138 mg, 1.2 mmol) to give compound 56 (305 mg, 48%), as in the preparation of compound 48.
  • 23
  • [ 2419-74-1 ]
  • [ 75-04-7 ]
  • [ 30727-14-1 ]
YieldReaction ConditionsOperation in experiment
66.1% In water; at 10 - 120℃; under 6750.68 Torr; for 10h;Autoclave; Sealed tube; General procedure: This embodiment is 3-hydroxy-1-methyl tetrahydropyrrole preparation method, the specific steps are as follows: A 500 mL four-necked flask was charged with 250 g of a 40 wt% aqueous solution of monomethylamine and cooled to 10 C in an ice-water bath. Then, while stirring, 102 g of 1,4-dichloro-2-butanol was added dropwise and the temperature was controlled at 15 C The following, about 15min drip finished; Then pour the system into 500mLAutoclave, sealed, evacuated to a pressure of 1.0 ± 0.1MPa, while heated to 120 ± 2 , the reaction was stirred for about 10h, GC control of raw materials disappear. After the reaction was over, cooled to room temperature, the material was discharged, batchwise add 110g of sodium hydroxide, release a large amount of methylamine gas, control the temperature below 50 , precipitated a lot of white solid, stirred for 1h; filtration, the filtrate layered, the upper organic phase Ethanol 100mLAnd anhydrous magnesium sulfate 18g, stirring 2 ~ 3h; and then filtered, the filtrate was concentrated in vacuo to give a yellow transparent oily liquid, and then vacuum distillation to give 46.7g of colorless and transparent 3-hydroxy-1-methyl tetrahydropyrrole , Yield 64.8%, purity 99.3% (HPLC).
 

Historical Records

Technical Information

Categories

Related Functional Groups of
[ 30727-14-1 ]

Alcohols

Chemical Structure| 104641-59-0

A133564 [104641-59-0]

(S)-(+)-1-Methyl-3-pyrrolidinol

Similarity: 1.00

Chemical Structure| 13220-33-2

A198212 [13220-33-2]

N-Methyl-3-pyrrolidinol

Similarity: 1.00

Chemical Structure| 104641-60-3

A273989 [104641-60-3]

(R)-3-Hydroxy-1-methyl-pyrrolidine

Similarity: 1.00

Chemical Structure| 40499-83-0

A174388 [40499-83-0]

Pyrrolidin-3-ol

Similarity: 0.92

Chemical Structure| 100243-39-8

A175317 [100243-39-8]

(S)-Pyrrolidin-3-ol

Similarity: 0.92

Related Parent Nucleus of
[ 30727-14-1 ]

Pyrrolidines

Chemical Structure| 104641-59-0

A133564 [104641-59-0]

(S)-(+)-1-Methyl-3-pyrrolidinol

Similarity: 1.00

Chemical Structure| 13220-33-2

A198212 [13220-33-2]

N-Methyl-3-pyrrolidinol

Similarity: 1.00

Chemical Structure| 104641-60-3

A273989 [104641-60-3]

(R)-3-Hydroxy-1-methyl-pyrrolidine

Similarity: 1.00

Chemical Structure| 40499-83-0

A174388 [40499-83-0]

Pyrrolidin-3-ol

Similarity: 0.92

Chemical Structure| 100243-39-8

A175317 [100243-39-8]

(S)-Pyrrolidin-3-ol

Similarity: 0.92